📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Polypharmacy: the good, the bad and the ugly. (2014)

First Author: Fleischhacker WW

Attributed to: MICA: STRATA - Schizophrenia: Treatment Resistance And Therapeutic Advances funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1017/s1461145713000965

PubMed Identifier: 23931546

Publication URI: http://europepmc.org/abstract/MED/23931546

Type: Journal Article/Review

Volume: 17

Parent Publication: The international journal of neuropsychopharmacology

Issue: 7

ISSN: 1461-1457